HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Infusion thrombophlebitis: a prospective comparison of 645 Vialon and Teflon cannulae in anaesthetic and postoperative use.

Abstract
A prospective study of the incidence and severity of infusion thrombophlebitis in peripheral intravenous infusions used for anaesthetic and postoperative purposes in 645 patients was conducted over a four-month period. Conditions of insertion were carefully controlled while ward management was according to standard practice. A total of 330 polyurethane Vialon and 315 FEP-A Teflon cannulae were used. The results show that the nature of the cannula was the single most important factor in the incidence and severity of infusion thrombophlebitis, Vialon cannulae being associated with a 46% lower incidence than the Teflon type. Less important but significant factors included intravenous antibiotics, duration of infusion, cannula tip damage and caesarean section. Factors not associated with infusion thrombophlebitis included potassium therapy, blood transfusion or site of insertion in the upper limb. Heparinisation increased duration of infusion without affecting the incidence of infusion thrombophlebitis.
AuthorsP B Gaukroger, J G Roberts, T A Manners
JournalAnaesthesia and intensive care (Anaesth Intensive Care) Vol. 16 Issue 3 Pg. 265-71 (Aug 1988) ISSN: 0310-057X [Print] United States
PMID3189736 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Polyurethanes
  • Resins, Synthetic
  • Vialon
  • Polytetrafluoroethylene
Topics
  • Adult
  • Anesthesia, Intravenous (adverse effects, instrumentation)
  • Catheterization, Peripheral (adverse effects, instrumentation)
  • Equipment Failure
  • Humans
  • Infusions, Intravenous (adverse effects, instrumentation)
  • Polytetrafluoroethylene
  • Polyurethanes
  • Prospective Studies
  • Resins, Synthetic
  • Thrombophlebitis (etiology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: